Cargando…

Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides

A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pospisilova, Sarka, Kos, Jiri, Michnova, Hana, Kapustikova, Iva, Strharsky, Tomas, Oravec, Michal, Moricz, Agnes M., Bakonyi, Jozsef, Kauerova, Tereza, Kollar, Peter, Cizek, Alois, Jampilek, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121455/
https://www.ncbi.nlm.nih.gov/pubmed/30087309
http://dx.doi.org/10.3390/ijms19082318
_version_ 1783352471959109632
author Pospisilova, Sarka
Kos, Jiri
Michnova, Hana
Kapustikova, Iva
Strharsky, Tomas
Oravec, Michal
Moricz, Agnes M.
Bakonyi, Jozsef
Kauerova, Tereza
Kollar, Peter
Cizek, Alois
Jampilek, Josef
author_facet Pospisilova, Sarka
Kos, Jiri
Michnova, Hana
Kapustikova, Iva
Strharsky, Tomas
Oravec, Michal
Moricz, Agnes M.
Bakonyi, Jozsef
Kauerova, Tereza
Kollar, Peter
Cizek, Alois
Jampilek, Josef
author_sort Pospisilova, Sarka
collection PubMed
description A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bipolaris sorokiniana. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2E)-3-phenyl-N-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M. tuberculosis. These compounds showed an activity against biofilm formation of S. aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2E)-N-(3,5-Dichlorophenyl)- and (2E)-N-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2E)-N-(3-Fluorophenyl)- and (2E)-N-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B. sorokiniana. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. (2E)-N-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC(50) = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure–activity relationships are discussed.
format Online
Article
Text
id pubmed-6121455
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61214552018-09-07 Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides Pospisilova, Sarka Kos, Jiri Michnova, Hana Kapustikova, Iva Strharsky, Tomas Oravec, Michal Moricz, Agnes M. Bakonyi, Jozsef Kauerova, Tereza Kollar, Peter Cizek, Alois Jampilek, Josef Int J Mol Sci Article A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bipolaris sorokiniana. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2E)-3-phenyl-N-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M. tuberculosis. These compounds showed an activity against biofilm formation of S. aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2E)-N-(3,5-Dichlorophenyl)- and (2E)-N-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2E)-N-(3-Fluorophenyl)- and (2E)-N-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B. sorokiniana. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. (2E)-N-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC(50) = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure–activity relationships are discussed. MDPI 2018-08-07 /pmc/articles/PMC6121455/ /pubmed/30087309 http://dx.doi.org/10.3390/ijms19082318 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pospisilova, Sarka
Kos, Jiri
Michnova, Hana
Kapustikova, Iva
Strharsky, Tomas
Oravec, Michal
Moricz, Agnes M.
Bakonyi, Jozsef
Kauerova, Tereza
Kollar, Peter
Cizek, Alois
Jampilek, Josef
Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides
title Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides
title_full Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides
title_fullStr Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides
title_full_unstemmed Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides
title_short Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides
title_sort synthesis and spectrum of biological activities of novel n-arylcinnamamides
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121455/
https://www.ncbi.nlm.nih.gov/pubmed/30087309
http://dx.doi.org/10.3390/ijms19082318
work_keys_str_mv AT pospisilovasarka synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT kosjiri synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT michnovahana synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT kapustikovaiva synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT strharskytomas synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT oravecmichal synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT moriczagnesm synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT bakonyijozsef synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT kauerovatereza synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT kollarpeter synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT cizekalois synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides
AT jampilekjosef synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides